Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Intravenous Ibuprofen Market contains market size and forecasts of Intravenous (IV) Ibuprofen in global, including the following market information:
- Global Intravenous (IV) Ibuprofen Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Intravenous (IV) Ibuprofen Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Intravenous (IV) Ibuprofen companies in 2021 (%)
The global Intravenous (IV) Ibuprofen market was valued at 7250.7 million in 2021 and is projected to reach US$ 14880 million by 2028, at a CAGR of 10.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100 mg Dose Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intravenous (IV) Ibuprofen include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals and Al Nabeel International and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravenous (IV) Ibuprofen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous (IV) Ibuprofen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, by Type, 2021 (%)
- 100 mg Dose
- 200 mg Dose
- 400 mg Dose
- 800 mg Dose
Global Intravenous (IV) Ibuprofen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, by Application, 2021 (%)
Global Intravenous (IV) Ibuprofen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Intravenous (IV) Ibuprofen Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Intravenous (IV) Ibuprofen revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Intravenous (IV) Ibuprofen revenues share in global market, 2021 (%)
- Key companies Intravenous (IV) Ibuprofen sales in global market, 2017-2022 (Estimated), (MT)
- Key companies Intravenous (IV) Ibuprofen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Cumberland Pharmaceuticals
- Alveda Pharmaceuticals
- CSL Limited
- Sandor Medicaids
- PT. Soho Industri Pharmasi
- Germin MED
- Grifols
- Gloria Pharmaceuticals
- Al Nabeel International
- Laboratorios Valmorca
Industry Market Size
